SkinHealth Systems Inc. Investing Cash Flow
SkinHealth Systems Inc. (SKIN) reported Investing Cash Flow of -$2.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$1.21M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$1.65M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.38M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$1.08M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$5.16M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$6.79M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$31.51M.
- SkinHealth Systems Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$18.87M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.85M 10-Q · filed 2026-08-06 | -$4.24M derived: sum of 3 quarters · filed 2026-08-06 | -$5.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.65M 10-Q · filed 2026-05-07 | -$3.03M derived: sum of 2 quarters · filed 2026-05-07 | -$4.12M derived: sum of 3 quarters · filed 2026-05-07 | -$5.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.47M derived: sum of 2 quarters · filed 2026-03-12 | -$4.02M derived: sum of 3 quarters · filed 2026-08-06 | -$5.16M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.64M derived: sum of 2 quarters · filed 2026-08-06 | -$3.78M 10-Q · filed 2025-11-06 | -$4.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.70M 10-Q · filed 2026-08-06 | -$3.56M derived: sum of 3 quarters · filed 2026-08-06 | -$5.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.15M 10-Q · filed 2026-05-07 | -$2.01M derived: sum of 2 quarters · filed 2026-05-07 | -$4.10M derived: sum of 3 quarters · filed 2026-05-07 | -$6.14M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$862.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.95M derived: sum of 2 quarters · filed 2026-03-12 | -$4.99M derived: sum of 3 quarters · filed 2026-03-12 | -$6.79M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.13M derived: sum of 2 quarters · filed 2025-11-06 | -$5.93M 10-Q · filed 2025-11-06 | -$8.10M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.84M 10-Q · filed 2025-08-07 | -$6.01M derived: sum of 3 quarters · filed 2026-03-12 | -$10.44M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$1.80M 10-Q · filed 2025-05-08 | -$3.97M derived: sum of 2 quarters · filed 2026-03-12 | -$8.41M derived: sum of 3 quarters · filed 2026-03-12 | -$11.63M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$6.60M derived: sum of 2 quarters · filed 2026-03-12 | -$9.82M derived: sum of 3 quarters · filed 2026-03-12 | -$31.51M 10-K · filed 2026-03-12 |
| 2023-09-30 | -$4.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$7.66M derived: sum of 2 quarters · filed 2024-11-12 | -$29.34M 10-Q · filed 2024-11-12 | -$32.16M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | -$3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$24.90M 10-Q · filed 2024-08-08 | -$27.73M derived: sum of 3 quarters · filed 2025-03-12 | -$35.47M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | -$21.68M 10-Q · filed 2024-05-09 | -$24.51M derived: sum of 2 quarters · filed 2025-03-12 | -$32.25M derived: sum of 3 quarters · filed 2025-03-12 | -$37.13M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | -$2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$10.56M derived: sum of 2 quarters · filed 2025-03-12 | -$15.44M derived: sum of 3 quarters · filed 2025-03-12 | -$18.87M 10-K · filed 2025-03-12 |
| 2022-09-30 | -$7.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$12.62M derived: sum of 2 quarters · filed 2023-11-14 | -$16.05M 10-Q · filed 2023-11-14 | -$24.57M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | -$4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$8.30M 10-Q · filed 2023-08-09 | -$16.83M derived: sum of 3 quarters · filed 2024-03-12 | -$36.92M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | -$3.42M 10-Q · filed 2023-05-10 | -$11.96M derived: sum of 2 quarters · filed 2024-03-12 | -$32.04M derived: sum of 3 quarters · filed 2024-03-12 | -$40.17M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | -$8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$28.61M derived: sum of 2 quarters · filed 2024-03-12 | -$36.74M derived: sum of 3 quarters · filed 2024-03-12 | -$37.73M 10-K · filed 2024-03-12 |
| 2021-09-30 | -$20.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$28.21M derived: sum of 2 quarters · filed 2022-11-09 | -$29.20M 10-Q · filed 2022-11-09 | -$30.32M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$8.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$9.12M 10-Q · filed 2022-08-09 | -$10.24M derived: sum of 3 quarters · filed 2023-03-01 | -$11.51M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$988.00K 10-Q · filed 2022-05-10 | -$2.11M derived: sum of 2 quarters · filed 2023-03-01 | -$3.38M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$460.00M 10-K/A · filed 2021-05-28 | -$3.82M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$2.70M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$1.43M 10-Q · filed 2021-08-13 | |||
| 2019-12-31 | -$12.48M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |